|
CA2913805A1
(en)
|
2005-11-07 |
2007-05-18 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting physiological solubility and stability
|
|
CN101578102B
(zh)
|
2007-01-05 |
2013-07-17 |
印第安纳大学研究及科技有限公司 |
在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物
|
|
WO2008101017A2
(en)
|
2007-02-15 |
2008-08-21 |
Indiana Unversity Research And Technology Corporation |
Glucagon/glp-1 receptor co-agonists
|
|
ES2509883T3
(es)
|
2007-10-30 |
2014-10-20 |
Indiana University Research And Technology Corporation |
Antagonistas de glucagón
|
|
MX2010004298A
(es)
|
2007-10-30 |
2010-05-03 |
Univ Indiana Res & Tech Corp |
Compuestos que exhiben actividad antagonista de glucagon y agonista de glp-1.
|
|
US8546327B2
(en)
|
2008-06-17 |
2013-10-01 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
|
PE20100056A1
(es)
|
2008-06-17 |
2010-01-26 |
Univ Indiana Res & Tech Corp |
Analogos de glucagon como agonistas gip
|
|
WO2009155257A1
(en)
|
2008-06-17 |
2009-12-23 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting enhanced solubility and stability physiological ph buffers
|
|
KR20110110174A
(ko)
|
2008-12-19 |
2011-10-06 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
아미드 기반 글루카곤 슈퍼패밀리 펩티드 프로드럭
|
|
WO2010096052A1
(en)
|
2009-02-19 |
2010-08-26 |
Merck Sharp & Dohme Corp. |
Oxyntomodulin analogs
|
|
CN102459325B
(zh)
|
2009-06-16 |
2015-03-25 |
印第安纳大学科技研究有限公司 |
胃抑胜肽受体活化的胰高血糖素化合物
|
|
RS53987B1
(en)
|
2009-07-13 |
2015-10-30 |
Zealand Pharma A/S |
ANALYSIS OF ACYLATED GLUCAGON
|
|
US8703701B2
(en)
|
2009-12-18 |
2014-04-22 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
|
JO2976B1
(en)
|
2009-12-22 |
2016-03-15 |
ايلي ليلي اند كومباني |
Axentomodulin polypeptide
|
|
JP2013518115A
(ja)
|
2010-01-27 |
2013-05-20 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション |
代謝疾患及び肥満の治療のためのグルカゴンアンタゴニスト‐ｇｉｐアゴニスト複合体及び組成物
|
|
AR081339A1
(es)
|
2010-04-27 |
2012-08-08 |
Zealand Pharma As |
Conjugados peptidicos
|
|
BR112012028704A2
(pt)
|
2010-05-13 |
2019-09-24 |
Univ Indiana Res & Tech Corp |
composto de glugagon da superfamília de peptídeos exibindo atividade do receptor com hormônio nuclear, pró fármaco, dímero ou multímero, composição farmacêutica que o compreendem e método de administração do mesmo.
|
|
CN103179976A
(zh)
|
2010-05-13 |
2013-06-26 |
印第安纳大学研究及科技有限公司 |
呈现g蛋白偶联受体活性的胰高血糖素超家族肽
|
|
CN103179979A
(zh)
|
2010-06-24 |
2013-06-26 |
印第安纳大学研究及科技有限公司 |
基于酰胺的胰高血糖素超家族肽前药
|
|
EA201390941A1
(ru)
|
2010-12-22 |
2013-12-30 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Аналоги глюкагона, проявляющие активность на рецепторе gip
|
|
WO2012150503A2
(en)
*
|
2011-05-03 |
2012-11-08 |
Zealand Pharma A/S |
Glu-glp-1 dual agonist signaling-selective compounds
|
|
WO2012153196A2
(en)
*
|
2011-05-10 |
2012-11-15 |
Zealand Pharma A/S |
Glu-glp-1 dual agonist signaling-selective compounds
|
|
UA126465C2
(uk)
|
2011-06-10 |
2022-10-12 |
Ханмі Сайенс Ко., Лтд. |
Пептид, що має активність оксинтомодуліну, та фармацевтична композиція для лікування ожиріння, яка його містить
|
|
RS58606B1
(sr)
*
|
2011-06-17 |
2019-05-31 |
Hanmi Science Co Ltd |
Konjugat koji sadrži oksintomodulin i imunoglobulinski fragment, i njegova upotreba
|
|
BR112013032717A2
(pt)
|
2011-06-22 |
2017-01-24 |
Univ Indiana Res & Tech Corp |
coagonistas do receptor de glucagon/glp-1
|
|
HRP20170890T1
(hr)
|
2011-06-22 |
2017-09-08 |
Indiana University Research And Technology Corporation |
Suagonisti glukagonskog/glp-1 receptora
|
|
WO2013004983A1
(en)
|
2011-07-04 |
2013-01-10 |
Imperial Innovations Limited |
Novel compounds and their effects on feeding behaviour
|
|
EA028951B9
(ru)
|
2011-11-03 |
2018-05-31 |
Зилэнд Фарма А/С |
Пептидные конъюгаты агониста рецептора гастрина и глюкагон подобного пептида 1
|
|
BR112014007124A2
(pt)
*
|
2011-11-17 |
2017-06-13 |
Univ Indiana Res & Tech Corp |
superfamília de peptídeos gluxagon que exibem atividade no receptor glicocorticóide
|
|
JP2015525226A
(ja)
*
|
2012-06-14 |
2015-09-03 |
サノフイ |
エキセンディン−４ペプチドアナログ
|
|
RU2015101697A
(ru)
|
2012-06-21 |
2016-08-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Аналоги глюкагона, обладающие активностью рецептора gip
|
|
EA033399B1
(ru)
|
2012-07-23 |
2019-10-31 |
Zealand Pharma As |
Аналоги глюкагона с повышенной растворимостью и/или стабильностью и их применение
|
|
KR101968344B1
(ko)
*
|
2012-07-25 |
2019-04-12 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
|
|
TWI608013B
(zh)
|
2012-09-17 |
2017-12-11 |
西蘭製藥公司 |
升糖素類似物
|
|
WO2014049610A2
(en)
|
2012-09-26 |
2014-04-03 |
Cadila Healthcare Limited |
Peptides as gip, glp-1 and glucagon receptors triple-agonist
|
|
UA116217C2
(uk)
|
2012-10-09 |
2018-02-26 |
Санофі |
Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
|
|
MY197849A
(en)
|
2012-11-06 |
2023-07-20 |
Hanmi Pharm Ind Co Ltd |
Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
|
|
KR101993393B1
(ko)
*
|
2012-11-06 |
2019-10-01 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
|
|
US20150344540A1
(en)
*
|
2012-12-19 |
2015-12-03 |
Novo Nordisk A/S |
Novel glp-1 receptor agonists with cholesterol efflux activity
|
|
SG11201503524PA
(en)
|
2012-12-21 |
2015-06-29 |
Sanofi Sa |
Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
|
|
EP2976325B1
(en)
|
2013-03-21 |
2017-03-01 |
Sanofi-Aventis Deutschland GmbH |
Synthesis of cyclic imide containing peptide products
|
|
US10087221B2
(en)
|
2013-03-21 |
2018-10-02 |
Sanofi-Aventis Deutschland Gmbh |
Synthesis of hydantoin containing peptide products
|
|
WO2014161835A1
(en)
|
2013-04-03 |
2014-10-09 |
Sanofi |
Modified blood glucose regulating proteins with altered pharmacological activity profile and preparation thereof
|
|
WO2015038938A1
(en)
*
|
2013-09-13 |
2015-03-19 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
|
CN119119235A
(zh)
|
2013-10-17 |
2024-12-13 |
西兰制药公司 |
酰化胰高血糖素类似物
|
|
US9988429B2
(en)
|
2013-10-17 |
2018-06-05 |
Zealand Pharma A/S |
Glucagon analogues
|
|
EA035466B9
(ru)
|
2013-11-06 |
2020-08-17 |
Зилэнд Фарма А/С |
Соединения и способы на основе двойного агониста гип и гпп-1
|
|
MX369770B
(es)
|
2013-11-06 |
2019-11-21 |
Zealand Pharma As |
Compuestos agonistas triples de glucagón-glp-1-gip.
|
|
TW201609797A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
雙重ｇｌｐ－１／升糖素受體促效劑
|
|
EP3080152A1
(en)
|
2013-12-13 |
2016-10-19 |
Sanofi |
Non-acylated exendin-4 peptide analogues
|
|
TW201609799A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
雙重ｇｌｐ－１／ｇｉｐ受體促效劑
|
|
TW201609800A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
做為雙重ｇｌｐ－１／升糖素受體促效劑之艾塞那肽－４胜肽類似物
|
|
TW201609795A
(zh)
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
作為雙重ｇｌｐ－１／ｇｉｐ受體促效劑的艾塞那肽－４（ｅｘｅｎｄｉｎ－４）胜肽類似物
|
|
EP3082797A4
(en)
|
2013-12-18 |
2017-12-13 |
The California Institute for Biomedical Research |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
|
KR20160114082A
(ko)
|
2014-02-18 |
2016-10-04 |
노보 노르디스크 에이/에스 |
안정한 글루카곤 유사체 및 저혈당증의 치료를 위한 용도
|
|
TW201625669A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑
|
|
TW201625668A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
|
|
TW201625670A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
|
|
US9932381B2
(en)
|
2014-06-18 |
2018-04-03 |
Sanofi |
Exendin-4 derivatives as selective glucagon receptor agonists
|
|
TWI772252B
(zh)
|
2014-09-16 |
2022-08-01 |
南韓商韓美藥品股份有限公司 |
長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
|
|
CN106519015B
(zh)
*
|
2014-09-23 |
2020-04-17 |
深圳市图微安创科技开发有限公司 |
胃泌酸调节素类似物
|
|
MX382408B
(es)
|
2014-10-24 |
2025-03-13 |
Merck Sharp & Dohme Llc |
Coagonistas de los receptores de glucagón y de glp-1.
|
|
MX381640B
(es)
|
2014-10-29 |
2025-03-04 |
Zealand Pharma As |
Metodos y compuestos agonistas de gip.
|
|
KR102418477B1
(ko)
|
2014-12-30 |
2022-07-08 |
한미약품 주식회사 |
글루카곤 유도체
|
|
AR103322A1
(es)
|
2014-12-30 |
2017-05-03 |
Hanmi Pharm Ind Co Ltd |
Derivados de glucagón con estabilidad mejorada
|
|
RU2735762C2
(ru)
|
2015-04-16 |
2020-11-06 |
Зилэнд Фарма А/С |
Ацилированный аналог глюкагона, его применение и способы получения
|
|
AR105319A1
(es)
|
2015-06-05 |
2017-09-27 |
Sanofi Sa |
Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
|
|
WO2016198628A1
(en)
|
2015-06-12 |
2016-12-15 |
Sanofi |
Non-acylated exendin-4 derivatives as dual glp-1/glucagon receptor agonists
|
|
WO2016198624A1
(en)
|
2015-06-12 |
2016-12-15 |
Sanofi |
Exendin-4 derivatives as trigonal glp-1/glucagon/gip receptor agonists
|
|
JP6882210B2
(ja)
*
|
2015-06-30 |
2021-06-02 |
ハンミ ファーマシューティカル カンパニー リミテッド |
グルカゴン誘導体及びその持続型結合体を含む組成物
|
|
AR105284A1
(es)
|
2015-07-10 |
2017-09-20 |
Sanofi Sa |
Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
|
|
EP3359191A4
(en)
|
2015-10-05 |
2019-05-29 |
Merck Sharp & Dohme Corp. |
ANTIBODY PEPTIDE CONJUGATES WITH AGONISTEACTIVITY ON GLUCAGON RECEPTORS AND GLUCAGON-LIKE PEPTIDE-1
|
|
WO2017062271A2
(en)
|
2015-10-06 |
2017-04-13 |
Merck Sharp & Dohme Corp. |
Antibody drug conjugate for anti-inflammatory applications
|
|
US10793615B2
(en)
|
2015-10-27 |
2020-10-06 |
Merck Sharp & Dohme Corp. |
Long-acting co-agonists of the glucagon and GLP-1 receptors
|
|
EP3394091A4
(en)
*
|
2015-12-09 |
2019-12-18 |
Merck Sharp & Dohme Corp. |
CO-AGONISTS OF GLUCAGON AND GLP-1 RECEPTORS
|
|
CN108699125B
(zh)
|
2015-12-31 |
2022-10-28 |
韩美药品株式会社 |
胰高血糖素/glp-1/gip受体三重激动剂
|
|
WO2017132103A2
(en)
|
2016-01-29 |
2017-08-03 |
Merck Sharp & Dohme Corp. |
Phosphonate linkers and their use to facilitate cellular retention of compounds
|
|
TN2018000452A1
(en)
*
|
2016-06-29 |
2020-06-15 |
Hanmi Pharm Ind Co Ltd |
Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
|
|
TW201832783A
(zh)
|
2016-12-02 |
2018-09-16 |
法商賽諾菲公司 |
包含ｇｌｐ－１／胰高血糖素雙重激動劑、連接子和透明質酸的接合物
|
|
AU2017371516C1
(en)
|
2016-12-09 |
2021-09-02 |
Zealand Pharma A/S |
Acylated GLP-1/GLP-2 dual agonists
|
|
CN108299553B
(zh)
*
|
2017-01-13 |
2021-07-16 |
博瑞生物医药（苏州）股份有限公司 |
胃泌酸调节素修饰物
|
|
CN106986924A
(zh)
*
|
2017-03-23 |
2017-07-28 |
中国药科大学 |
胃泌酸调节素（oxm）类似物及其应用
|
|
MX2020001761A
(es)
*
|
2017-08-16 |
2020-07-29 |
Dong A St Co Ltd |
Analogo de peptido de oxintomodulina acilado.
|
|
MX2020003217A
(es)
|
2017-09-25 |
2020-07-29 |
Merck Sharp & Dohme |
Coagonistas de accion prolongada de los receptores de glucagon y glp-1.
|
|
CN109836488B
(zh)
*
|
2017-11-24 |
2022-08-23 |
浙江道尔生物科技有限公司 |
一种治疗代谢疾病的胰高血糖素类似物
|
|
CN109836504B
(zh)
*
|
2017-11-24 |
2022-08-02 |
浙江道尔生物科技有限公司 |
一种治疗代谢疾病的多结构域活性蛋白
|
|
CN111171135B
(zh)
*
|
2018-11-12 |
2023-04-07 |
天津药物研究院有限公司 |
具有双重受体激动作用的胰高血糖素衍生肽及其用途
|
|
BR112021011595A2
(pt)
|
2018-12-21 |
2021-11-30 |
Jiangsu Hengrui Medicine Co |
Proteína biespecífica
|
|
US11471512B2
(en)
|
2019-03-01 |
2022-10-18 |
Merck Sharp & Dohme Llc |
Pharmaceutical compositions of a peptide
|
|
CN110684082B
(zh)
*
|
2019-10-08 |
2021-12-10 |
江苏诺泰澳赛诺生物制药股份有限公司 |
Gip和glp-1双激动多肽化合物及药学上可接受的盐与用途
|
|
EP3842060A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled lactam co-agonists of the glucagon and glp-1 receptors
|
|
EP3842061A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled triazole co-agonists of the glucagon and glp-1 receptors
|
|
EP3842449A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled olefin co-agonists of the glucagon and glp-1 receptors
|
|
US20230174608A1
(en)
*
|
2020-05-09 |
2023-06-08 |
Tianjin Institute Of Pharmaceutical Research Co., Ltd. |
Polypeptide Derivative Having Dual Receptor Agonistic Action and Use Thereof
|
|
CN112898405B
(zh)
*
|
2021-01-22 |
2023-02-28 |
深圳市图微安创科技开发有限公司 |
多肽化合物及其在预防或治疗糖尿病或糖尿病并发症中的应用
|
|
CN117794946A
(zh)
|
2021-06-09 |
2024-03-29 |
斯克利普斯研究所 |
长效双重gip/glp-1肽缀合物及使用方法
|
|
CN119930789A
(zh)
*
|
2023-11-06 |
2025-05-06 |
成都奥达生物科技有限公司 |
一种gcg激动剂化合物
|